(Total Views: 574)
Posted On: 04/24/2025 9:15:10 AM
Post# of 154723
Quote:
What is Gilead's hope/intention by combining with Keytruda for tumors that express PD-L1?
I expect Gilead is looking to get Sacituzumab Govitecan-hziy used earlier in treatment. For PD-L1 expressing tumors, pembro + chemo is probably first line treatment in mTNBC. Gilead wants Sacituzumab Govitecan-hziy + pembro to be new first line.
(4)
(0)
